Hurteau J - Search Results

1

The risk of nodal metastasis in early adenocarcinoma of the uterine cervix.

Balega J, Michael H, Hurteau J, Moore DH, Santiesteban J, Sutton GP, Look KY. Balega J, et al. Among authors: hurteau j. Int J Gynecol Cancer. 2004 Jan-Feb;14(1):104-9. doi: 10.1111/j.1048-891x.2004.14079.x. Int J Gynecol Cancer. 2004. PMID: 14764037

2

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.

Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K. Nelson G, et al. Among authors: hurteau j. Gynecol Oncol. 1999 Nov;75(2):211-4. doi: 10.1006/gyno.1999.5569. Gynecol Oncol. 1999. PMID: 10525373

3

Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1.

Hurteau JA, Allison B, Sutton GP, Moore DH, Look KY, Hurd W, Bigsby RM. Hurteau JA, et al. Cancer. 1999 Apr 15;85(8):1810-5. doi: 10.1002/(sici)1097-0142(19990415)85:8<1810::aid-cncr22>3.0.co;2-e. Cancer. 1999. PMID: 10223576

4

Gynecologic cancers metastatic to the breast.

Moore DH, Wilson DK, Hurteau JA, Look KY, Stehman FB, Sutton GP. Moore DH, et al. Among authors: hurteau ja. J Am Coll Surg. 1998 Aug;187(2):178-81. doi: 10.1016/s1072-7515(98)00119-7. J Am Coll Surg. 1998. PMID: 9704965

5

Trisomy 21 associated with ovarian dysgerminoma.

Smucker JD, Roth LM, Sutton GP, Hurteau JA. Smucker JD, et al. Among authors: hurteau ja. Gynecol Oncol. 1999 Sep;74(3):512-4. doi: 10.1006/gyno.1999.5453. Gynecol Oncol. 1999. PMID: 10479522 Review.

6

A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery.

Schilder JM, Hurteau JA, Look KY, Moore DH, Raff G, Stehman FB, Sutton GP. Schilder JM, et al. Among authors: hurteau ja. Gynecol Oncol. 1997 Dec;67(3):235-40. doi: 10.1006/gyno.1997.4860. Gynecol Oncol. 1997. PMID: 9441769 Clinical Trial.

7

Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.

Markman M, Kennedy A, Sutton G, Hurteau J, Webster K, Peterson G, Kulp B, Belinson J. Markman M, et al. Among authors: hurteau j. Gynecol Oncol. 1998 Aug;70(2):272-4. doi: 10.1006/gyno.1998.5065. Gynecol Oncol. 1998. PMID: 9740704 Clinical Trial.

8

Villoglandular adenocarcinoma of the cervix: a case report.

Hurteau JA, Rodriguez GC, Kay HH, Bentley RC, Clarke-Pearson D. Hurteau JA, et al. Obstet Gynecol. 1995 May;85(5 Pt 2):906-8. doi: 10.1016/0029-7844(94)00418-d. Obstet Gynecol. 1995. PMID: 7724158

9

Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.

Kim JS, Mills KA, Fehniger J, Liao C, Hurteau JA, Kirschner CV, Lee NK, Rodriguez GC, Yamada SD, Diaz Moore ES, Tenney ME. Kim JS, et al. Among authors: hurteau ja. Int J Gynecol Cancer. 2017 Oct;27(8):1774-1782. doi: 10.1097/IGC.0000000000001084. Int J Gynecol Cancer. 2017. PMID: 28708786

10

Cardiac metastasis from poorly differentiated carcinoma of the cervix: a case report.

Miller ES, Hoekstra AV, Hurteau JA, Rodriguez GC. Miller ES, et al. J Reprod Med. 2010 Jan-Feb;55(1-2):78-80. J Reprod Med. 2010. PMID: 20337214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters